「Amoebiasis」の版間の差分
ナビゲーションに移動
検索に移動
Vaccipedia.admin (トーク | 投稿記録) |
Vaccipedia.admin (トーク | 投稿記録) 細 (Vaccipedia.admin がページ「Amoebasis」を「Amoebiasis」に移動しました) |
||
(同じ利用者による、間の4版が非表示) | |||
1行目: | 1行目: | ||
+ | {{TM menu}} | ||
+ | |||
==''Entamoeba histolytica''== | ==''Entamoeba histolytica''== | ||
===epidemiology=== | ===epidemiology=== | ||
29行目: | 31行目: | ||
**flask-shaped ulcer in histpathology | **flask-shaped ulcer in histpathology | ||
*advanced disease mimics ulcerative colitis and Crohn's disease | *advanced disease mimics ulcerative colitis and Crohn's disease | ||
+ | |||
+ | ====amoebic liver abscess (ALA)==== | ||
+ | *right lobe: left lobe =4:1 | ||
+ | *male: female=10:1 | ||
+ | *all age groups | ||
+ | **most common in 20-40 y/o | ||
+ | *>50% of patients have no previous dysentery | ||
===morphology=== | ===morphology=== | ||
*trophozoite 20-50 μm | *trophozoite 20-50 μm | ||
*cyst has 4 nuclei, each nucleus has a nucleolus | *cyst has 4 nuclei, each nucleus has a nucleolus | ||
+ | |||
+ | ===treatment=== | ||
+ | *metronidazole for trophozoite | ||
+ | *paromomycin for cyst eradication | ||
==''Entamoeba dispar''== | ==''Entamoeba dispar''== |
2021年5月31日 (月) 10:05時点における最新版
Navigation Menu |
General issues of Vaccine | |||||||
---|---|---|---|---|---|---|---|
|
General issues of Travel med. | ||||||||
---|---|---|---|---|---|---|---|---|
|
Immunology | |||||||
---|---|---|---|---|---|---|---|
|
Epi & Stats | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Virus | |||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
COVID-19 | |||||
---|---|---|---|---|---|
|
Bacteria | ||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Rickettsia | |||||
---|---|---|---|---|---|
|
Protozoa | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Fungi | |||||||
---|---|---|---|---|---|---|---|
|
Nematode (roundworm) | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Trematode (fluke, distoma) | |||||||
---|---|---|---|---|---|---|---|
|
Cestode (tapeworm) | ||||||
---|---|---|---|---|---|---|
|
Medical Zoology | ||||||||
---|---|---|---|---|---|---|---|---|
|
目次
Entamoeba histolytica
epidemiology
- worldwide
- 40-50 mil. symptomatic cases per year
- number of asymptomatic cases unknown
- 40,000-50,000 per year
- sexual transmission in developed countries
life cycle and pathophysiology
- feco-oral infection of cyst
- hutch in small intestine into trophozoite
- reside in large intestine
- propagate by binary fission
- some penetrate large intestine wall
- bloody diarrea
- trophozoites phagocityze RBC
- only RBC phagocitizing trophozoite means infection
- non-RBC-phagocitizing trophozoite means colonization
- some invade into portal vein through liver
- liver abscess
- some encyst in large intestine
- cysts are excreted from anus
clinical manifestation
- incubation a few days to years
- 80% of infection are asymptomatic
- mild, extensive, extreme
- large intestine ulcer
- flask-shaped ulcer in histpathology
- advanced disease mimics ulcerative colitis and Crohn's disease
amoebic liver abscess (ALA)
- right lobe: left lobe =4:1
- male: female=10:1
- all age groups
- most common in 20-40 y/o
- >50% of patients have no previous dysentery
morphology
- trophozoite 20-50 μm
- cyst has 4 nuclei, each nucleus has a nucleolus
treatment
- metronidazole for trophozoite
- paromomycin for cyst eradication
Entamoeba dispar
- formerly named as E. histolytica in 1903
- non-pathogenic type of old E. histolytica was distinguished as E. dispar in 1925
distribution
- E. disper vs E. histolytica
- 3:1 in developing countries
- 10:1 in developed countries
Entamoeba coli
- 6 nuclei in cyst